Drug Testing Locations - Franklin, WI

Drug Testing in Franklin, WI

Franklin, Wisconsin Statistics

In Franklin, WI, Milwaukee County recorded a 9% increase in drug-related hospital admissions in 2020.

The Franklin Police Department reported a 15% rise in drug possession arrests over the past year.

Franklin's opioid overdose death rate increased by 12% from 2019 to 2020, according to Milwaukee County data.

Milwaukee County's Community Health Assessments show that 18% of Franklin's youth have experimented with drugs.

In a 2021 survey, 25% of Franklin adults admitted to using prescription drugs non-medically.

Milwaukee County's Public Health Department noted a significant reduction in new drug rehab enrollments in Franklin during 2020.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Franklin, WI & Drug Testing Policies

Employers in Franklin, WI, actively implement drug testing policies to maintain workplace safety and productivity. Many adhere to the drug-free workplace guidelines set by federal agencies such as the Substance Abuse and Mental Health Services Administration (SAMHSA). This includes pre-employment, random, and post-accident testing.

Organizations also offer employee assistance programs (EAPs) to support workers struggling with substance abuse. These EAPs provide confidential counseling and resources, encouraging employees to seek help without fear of retribution. Some companies work closely with local rehab centers to facilitate treatment programs.

Additionally, compliance with the U.S. Department of Transportation's regulations is necessary for businesses that rely on commercial transportation services in Franklin. This ensures that employees operating vehicles or heavy machinery maintain sober and alert conditions at work.

Government Efforts with Drug Problems in Franklin, WI

The government of Franklin, WI, in Milwaukee County, is steadfastly addressing drug problems through community outreach and support programs. Local initiatives emphasize education and prevention, aiming to reduce substance abuse rates. These efforts are supported by the Wisconsin Department of Health Services and Milwaukee County's Department of Health and Human Services.

The city collaborates with federal bodies such as the Drug Enforcement Administration (DEA) to control drug trafficking. Strategies include enhanced law enforcement training, community-based interventions, and the use of data analytics to identify and address high-risk areas.

Local Drug Busts & News in Franklin, WI

Recent local drug busts in Franklin, WI, highlight ongoing law enforcement efforts to curb illegal activities. An operation led by the Milwaukee County Sheriff's Office resulted in several arrests, targeting a large-scale distribution network. The operation seized significant quantities of opioids and cocaine, underscoring the area's battle against narcotics.

Community events aimed at prevention and awareness also play a crucial role. Franklin hosts annual Drug Take-Back initiatives, facilitated by the DEA's National Prescription Drug Take Back Day, allowing residents to safely dispose of unused medications.

Educational seminars and workshops, collaboratively organized by local schools and the health department, educate the community, especially youth, about the dangers of drug use. By integrating such programs, Franklin aims to foster a more informed and safer community.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Franklin, WI. Trusted by employers nationwide for accurate results and exceptional service.

Wisconsin DOT/Non DOT Physicals

Wisconsin Vision Tests

Wisconsin Audiograms

Wisconsin Respirator Fit Tests

Wisconsin Lift Tests

Wisconsin Background Checks

Clinical Testing Services

TB Testing in WI

Diabetes Testing in WI

Infectious Disease Testing in WI

Sickle Cell Anemia Testing in WI

Women/Men's Health Testing in WI

Resources & Citations

Wisconsin Department of Health Services

Milwaukee County's Department of Health and Human Services

Substance Abuse and Mental Health Services Administration (SAMHSA)

Wisconsin Department of Administration

Wisconsin Department of Justice

United Way of Greater Milwaukee & Waukesha County

NAMI Waukesha

MCW Wisconsin o-drug Project

IMPACT 211 o-drug Crisis

Drug Free Communities - Milwaukee

Drug Testing Near Franklin, WI

Big Bend, WI

Caledonia, WI

Norway, WI

Fairview, WI

North Cape, WI

Wind Lake, WI

New Berlin, WI

Raymond, WI

Greenfield, WI

Muskego, WI

Greendale, WI

Hales Corners, WI

Frequently Asked Questions

Customer Reviews